Applied StemCell, Inc. Announces The Appointment Of Dr. Stanford Professor And Vice President Of To Its (SAB) Post author:Sam Post published:March 5, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Celgene Takes a $411M Hit From Discontinuation of Crohn's Disease Trials December 28, 2017 AbbVie Wins FDA Approval for the First-Ever Drug to Treat All Forms of Hep C August 3, 2017 FDA Approves Genentech's Zelboraf, the First-Ever Drug to Treat Specific Rare Blood Disease November 6, 2017
FDA Approves Genentech's Zelboraf, the First-Ever Drug to Treat Specific Rare Blood Disease November 6, 2017